Paper35366608
Lipoprotein oxidation may underlie the paradoxical association of low cholesterol with coronary atherosclerotic risk in rheumatoid arthritis.
Karpouzas GA and 4 others. J Autoimmun, 2022. Cited by 19 papers, by iCite.
Cite this record
ConductScience Library. Lipoprotein oxidation may underlie the paradoxical association of low cholesterol with coronary atherosclerotic risk in rheumatoid arthritis. Papers, record 35366608. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/35366608
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Lipoprotein oxidation may underlie the paradoxical association of low cholesterol with coronary atherosclerotic risk in rheumatoid arthritis.
- PubMed
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Arthritis, Rheumatoid | Major topic |
| Atherosclerosis | Major topic |
| C-Reactive Protein | |
| Cholesterol, LDL | |
| Humans | |
| Interleukin-6 | |
| Lipoprotein(a) | |
| Lipoproteins, LDL | |
| Proprotein Convertase 9 | |
| Tumor Necrosis Factor-alpha |
Source PubMed
Cited by13
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 19 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42582123 | Lipid parameters and disease activity in rheumatoid arthritis: a cross-sectional analysis of the Kuwait registry for rheumatic diseases (KRRD). | Front Med (Lausanne) | 2026 | https://conductscience.org/library/papers/42582123 | PubMed |
| 42548760 | Immunological heterogeneity in rheumatoid arthritis: challenges in early-stage stratification, non-response to targeted therapy, and the restoration of immune tolerance. | Front Immunol | 2026 | https://conductscience.org/library/papers/42548760 | PubMed |
| 42183228 | RORα: a critical nexus in the crosstalk between cholesterol metabolism and macrophage polarization. | Front Immunol | 2026 | https://conductscience.org/library/papers/42183228 | PubMed |
| 42099596 | Atherosclerosis features in rheumatic diseases - focus on peripheral artery disease. | Front Immunol | 2026 | https://conductscience.org/library/papers/42099596 | PubMed |
| 42051524 | Lipid metabolism at the intersection of rheumatoid arthritis and atherosclerosis. | Front Immunol | 2026 | https://conductscience.org/library/papers/42051524 | PubMed |
| 41360604 | Sex and reproductive stage modify the effect of endogenous oestrogens on coronary atherosclerosis in rheumatoid arthritis. | RMD Open | 2025 | https://conductscience.org/library/papers/41360604 | PubMed |
| 40943434 | Post-Translational Modifications of Lipoproteins: Emerging Players Linking Inflammation and Cardiovascular Disease in Rheumatoid Arthritis-A Narrative Review. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/40943434 | PubMed |
| 40176397 | Metabolic Consequences of Rheumatoid Arthritis. | Arthritis Care Res (Hoboken) | 2025 | https://conductscience.org/library/papers/40176397 | PubMed |
| 39831939 | Cardiovascular Risk Factor and Atherosclerosis in Rheumatoid Arthritis (RA). | Curr Cardiol Rep | 2025 | https://conductscience.org/library/papers/39831939 | PubMed |
| 39719397 | Changes in serum cholesterol loading capacity are linked to coronary atherosclerosis progression in rheumatoid arthritis. | RMD Open | 2024 | https://conductscience.org/library/papers/39719397 | PubMed |
| 39456762 | The Composition of the HDL Particle and Its Capacity to Remove Cellular Cholesterol Are Associated with a Reduced Risk of Developing Active Inflammatory Rheumatoid Arthritis. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/39456762 | PubMed |
| 36411486 | Prevalence and influence of hypouricemia on cardiovascular diseases in patients with rheumatoid arthritis. | Eur J Med Res | 2022 | https://conductscience.org/library/papers/36411486 | PubMed |
| 35955522 | Relationship between Brain Metabolic Disorders and Cognitive Impairment: LDL Receptor Defect. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/35955522 | PubMed |
Genes4
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CRP | 1401 | PubTator's text mining | https://conductscience.org/library/genes/1401 | NCBI Gene |
| IL6 | 3569 | PubTator's text mining | https://conductscience.org/library/genes/3569 | NCBI Gene |
| PCSK9 | 255738 | PubTator's text mining | https://conductscience.org/library/genes/255738 | NCBI Gene |
| TNF | 7124 | PubTator's text mining | https://conductscience.org/library/genes/7124 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/35366608
GET https://conductscience.org/api/papers/v1/35366608/authors